Literature DB >> 2117508

Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats.

J A Voorthuis1, B M Uitdehaag, C J De Groot, P H Goede, P H van der Meide, C D Dijkstra.   

Abstract

Experimental allergic encephalomyelitis (EAE) is an autoimmune inflammatory disease of the central nervous system (CNS) which causes paralysis. Several studies have reported the involvement of Ia antigen-expressing cells in the pathogenesis of EAE. Interferon-gamma (IFN-gamma) can induce Ia antigen expression on a wide range of cells. We examined the effect of IFN-gamma on EAE in Lewis rats. Systemically administered IFN-gamma did not change the disease course of EAE, whereas IFN-gamma applied locally into the ventricular system of the CNS resulted in complete suppression of clinical signs. Furthermore, we found that systemic administration of anti-IFN-gamma just prior to the onset of clinical symptoms resulted in a more severe disease course. We conclude that IFN-gamma is capable of exerting a suppressive action in EAE, possibly through induction of Ia antigen expression or through the induction of suppressive mechanisms locally in the CNS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117508      PMCID: PMC1535058          DOI: 10.1111/j.1365-2249.1990.tb03315.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Modulation of suppressor T cell induction with gamma-interferon.

Authors:  T Noma; M E Dorf
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

2.  Astrocytes present myelin basic protein to encephalitogenic T-cell lines.

Authors:  A Fontana; W Fierz; H Wekerle
Journal:  Nature       Date:  1984 Jan 19-25       Impact factor: 49.962

3.  The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3.

Authors:  C D Dijkstra; E A Döpp; P Joling; G Kraal
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

4.  The effect of Freund's adjuvants on blood-cerebrospinal fluid barrier permeability.

Authors:  H Reiber; A J Suckling; M G Rumsby
Journal:  J Neurol Sci       Date:  1984-01       Impact factor: 3.181

5.  In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis.

Authors:  L Steinman; J T Rosenbaum; S Sriram; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

6.  la-positive T lymphocytes are the producer cells of interferon gamma.

Authors:  I Schober; R Braun; H Reiser; K Munk; M Leroux; H Kirchner
Journal:  Exp Cell Res       Date:  1984-06       Impact factor: 3.905

7.  Inducible expression of H-2 and Ia antigens on brain cells.

Authors:  G H Wong; P F Bartlett; I Clark-Lewis; F Battye; J W Schrader
Journal:  Nature       Date:  1984 Aug 23-29       Impact factor: 49.962

8.  Cloning and expression of the chromosomal immune interferon gene of the rat.

Authors:  R Dijkema; P H van der Meide; P H Pouwels; M Caspers; M Dubbeld; H Schellekens
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

9.  Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes.

Authors:  S Sriram; L Steinman
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

10.  Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor.

Authors:  L P Svedersky; C V Benton; W H Berger; E Rinderknecht; R N Harkins; M A Palladino
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

View more
  57 in total

1.  Infection of non-encapsulated species of Trichinella ameliorates experimental autoimmune encephalomyelitis involving suppression of Th17 and Th1 response.

Authors:  Zhiliang Wu; Isao Nagano; Kazunobu Asano; Yuzo Takahashi
Journal:  Parasitol Res       Date:  2010-07-27       Impact factor: 2.289

2.  Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.

Authors:  J B Sun; C Rask; T Olsson; J Holmgren; C Czerkinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 3.  Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease.

Authors:  Ali Raza; Wajeeha Yousaf; Ralph Giannella; Mohamed Tarek Shata
Journal:  Expert Rev Clin Immunol       Date:  2012-02       Impact factor: 4.473

Review 4.  Major histocompatibility complex molecules on parenchymal cells of the target organ protect against autoimmune disease.

Authors:  Hui Shao; Henry J Kaplan; Deming Sun
Journal:  Chem Immunol Allergy       Date:  2007

5.  Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.

Authors:  Yong Chan Kim; Ai-Hong Zhang; Jeongheon Yoon; William E Culp; Jason R Lees; Kai W Wucherpfennig; David W Scott
Journal:  J Autoimmun       Date:  2018-05-30       Impact factor: 7.094

Review 6.  The role of macrophage subpopulations in autoimmune disease of the central nervous system.

Authors:  J Bauer; S R Ruuls; I Huitinga; C D Dijkstra
Journal:  Histochem J       Date:  1996-02

Review 7.  Mechanisms of action of interferon-beta in multiple sclerosis.

Authors:  B G Arnason; A Dayal; Z X Qu; M A Jensen; K Genç; A T Reder
Journal:  Springer Semin Immunopathol       Date:  1996

8.  Anti-inflammatory role of IL-17 in experimental autoimmune uveitis.

Authors:  Yan Ke; Ke Liu; Guo-Qiang Huang; Yan Cui; Henry J Kaplan; Hui Shao; Deming Sun
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

9.  Membrane estrogen receptor regulates experimental autoimmune encephalomyelitis through up-regulation of programmed death 1.

Authors:  Chunhe Wang; Babak Dehghani; Yuexin Li; Laurie J Kaler; Thomas Proctor; Arthur A Vandenbark; Halina Offner
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 10.  Oligodendroglial response to the immune cytokine interferon gamma.

Authors:  B Popko; K D Baerwald
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.